儿童中耳胆脂瘤诊治进展

doi:10.6040/j.issn.1673-3770.0.2021.503

摘要/Abstract

摘要： 儿童中耳胆脂瘤在患病率、发病机制与临床表现等方面都具有人群的特殊性。其起病隐匿,早期诊治成为临床难点。随着对儿童中耳胆脂瘤认识的提高和普及,临床中对此疾病的关注度明显提高。临床分期的应用及手术治疗的精准性趋于完善,伴有腭裂、特纳综合征、唐氏综合症等特殊人群的中耳胆脂瘤患儿的远期预后管理也得到了重视。

关键词: 儿童, 中耳胆脂瘤, 病理生理, 临床分期, 手术策略

Abstract: Middle ear cholesteatoma in children has population specificity in terms of prevalence, pathogenesis, and clinical manifestations. Due to its gradual onset, early diagnosis and treatment have become difficult clinically. With the improvement and popularization of middle ear cholesteatoma in children, this disease is becoming of increasing interest. The application of clinical staging and the accuracy of surgical treatment have greatly improved. The long-term prognosis management of middle ear cholesteatoma in children with cleft palate, Turner syndrome, Down syndrome, and other special populations has also been given importance.

Key words: Children, Middle ear cholesteatoma, Pathophysiology, Clinical stage, Surgical strategy

中图分类号:

R764.29

杨扬, 王晓旭, 张杰. 儿童中耳胆脂瘤诊治进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 1-6.

YANG Yang, WANG Xiaoxu, ZHANG Jie. Progress on diagnosis and treatment of middle ear cholesteatoma in children[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 1-6.

参考文献

[1] Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma[J]. J Int Adv Otol, 2017, 13(1): 1-8. doi:10.5152/iao.2017.3363.
[2] Jackson R, Addison AB, Prinsley PR. Cholesteatoma in children and adults: are there really any differences?[J]. J Laryngol Otol, 2018, 132(7): 575-578. doi:10.1017/S0022215118000890.
[3] Nevoux J, Lenoir M, Roger G, et al. Childhood cholesteatoma[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2010, 127(4): 143-150. doi:10.1016/j.anorl.2010.07.001.
[4] Thomas JP, Volkenstein S, Minovi A, et al. Current aspects of paediatric cholesteatomas[J]. HNO, 2013, 61(5): 380-387. doi:10.1007/s00106-012-2641-8.
[5] Minovi A, Dazert S. Diseases of the middle ear in childhood[J]. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2014, 13: Doc11. doi:10.3205/cto000114.
[6] Johannes ML. Ueber den feinern Bau und die Formen der krankhaften Geschwuülste [M]. Berlin: G. Reimer, 1838.
[7] Shin SH, Huang M, Kim SH, et al. Differential protein expression in congenital and acquired cholesteatomas[J]. PLoS One, 2015, 10(9): e0137011. doi:10.1371/journal.pone.0137011.
[8] Lindeman P, Holmquist J. Mastoid volume and eustachian tube function in ears with cholesteatoma[J]. Am J Otol, 1987, 8(1): 5-7.
[9] Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research[J]. Laryngoscope, 2015, 125(1): 234-240. doi:10.1002/lary.24890.
[10] Yamamoto-Fukuda T, Akiyama N, Tatsumi N, et al. Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo[J]. Int J Pediatr Otorhinolaryngol, 2021, 140: 110545. doi:10.1016/j.ijporl.2020.110545.
[11] Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research[J]. Biomed Res Int, 2015, 2015: 854024. doi:10.1155/2015/854024.
[12] Uzun T, Çaklı H, Co??塂an DT, et al. In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma[J]. Int J Pediatr Otorhinolaryngol, 2021, 145: 110743. doi:10.1016/j.ijporl.2021.110743.
[13] Maniu A, Harabagiu O, Perde Schrepler M, et al. Molecular biology of cholesteatoma[J]. Romanian J Morphol Embryol, 2014, 55(1): 7-13.
[14] Fontes Lima A, Carvalho Moreira F, Sousa Menezes A, et al. Is pediatric cholesteatoma more aggressive in children than in adults? A comparative study using the EAONO/JOS classification[J]. Int J Pediatr Otorhinolaryngol, 2020, 138: 110170. doi:10.1016/j.ijporl.2020.110170.
[15] Preciado DA. Biology of cholesteatoma: special considerations in pediatric patients[J]. Int J Pediatr Otorhinolaryngol, 2012, 76(3): 319-321. doi:10.1016/j.ijporl.2011.12.014.
[16] Derlacki EL, Clemis JD. Congenital cholesteatoma of the middle ear and mastoid[J]. Ann Otol Rhinol Laryngol, 1965, 74(3): 706-727. doi:10.1177/000348946507400313.
[17] Levenson MJ, Michaels L, Parisier SC. Congenital cholesteatomas of the middle ear in children: origin and management[J]. Otolaryngol Clin North Am, 1989, 22(5): 941-954.
[18] Potsic WP, Samadi DS, Marsh RR, et al. A staging system for congenital cholesteatoma[J]. Arch Otolaryngol Head Neck Surg, 2002, 128(9): 1009-1012. doi:10.1001/archotol.128.9.1009.
[19] Nelson M, Roger G, Koltai PJ, et al. Congenital cholesteatoma: classification, management, and outcome[J]. Arch Otolaryngol Head Neck Surg, 2002, 128(7): 810-814. doi:10.1001/archotol.128.7.810.
[20] Rutkowska J, Özgirgin N, Olszewska E. Cholesteatoma definition and classification: a literature review[J]. J Int Adv Otol, 2017, 13(2): 266-271. doi:10.5152/iao.2017.3411.
[21] Lau T, Tos M. Tensa retraction cholesteatoma: treatment and long-term results[J]. J Laryngol Otol, 1989, 103(2): 149-157. doi:10.1017/s0022215100108321.
[22] Merkus P, Ten Tije FA, Stam M, et al. Implementation of the “EAONO/JOS definitions and classification of middle ear cholesteatoma”-from STAM to STAMCO[J]. J Int Adv Otol, 2017, 13(2): 272-275. doi:10.5152/iao.2017.4049.
[23] Linder TE, Shah S, Martha AS, et al. Introducing the “ChOLE” classification and its comparison to the EAONO/JOS consensus classification for cholesteatoma staging[J]. Otol Neurotol, 2019, 40(1): 63-72. doi:10.1097/MAO.0000000000002039.
[24] Cacco T, Africano S, Gaglio G, et al. Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications[J]. Eur Arch Otorhinolaryngol, 2021: 22. doi:10.1007/s00405-021-06679-8.
[25] van der Toom H, van der Schroeff MP, Janssen J, et al. A retrospective analysis and comparison of the STAM and STAMCO classification and EAONO/JOS cholesteatoma staging system in predicting surgical treatment outcomes of middle ear cholesteatoma[J]. Otol Neurotol, 2020, 41(4): e468-e474. doi:10.1097/MAO.0000000000002549.
[26] Ten Tije FA, Merkus P, Buwalda J, et al. Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care [J]. Eur Arch Otorhinolaryngol,2021,278(10):3777-3787. doi: 10.1007/s00405-020-06478-7.
[27] Bächinger D, Rrahmani A, Weiss NM, et al. Evaluating hearing outcome, recidivism and complications in cholesteatoma surgery using the ChOLE classification system[J]. Eur Arch Otorhinolaryngol, 2021, 278(5): 1365-1371. doi:10.1007/s00405-020-06208-z.
[28] Dixon PR, James AL. Evaluation of residual disease following transcanal totally endoscopic vs postauricular surgery among children with middle ear and attic cholesteatoma[J]. JAMA Otolaryngol Head Neck Surg, 2020, 146(5): 408-413. doi:10.1001/jamaoto.2020.0001.
[29] Nogueira JF, Cohen MS. Combined endoscopic and microscopic approaches to cholesteatoma[J]. Oper Tech Otolaryngol - Head Neck Surg, 2017, 28(1): 36-38. doi:10.1016/j.otot.2017.01.006.
[30] Denoyelle F, Simon F, Chang KW, et al. International pediatric otolaryngology group(IPOG)consensus recommendations: congenital cholesteatoma[J]. Otol Neurotol, 2020, 41(3): 345-351. doi:10.1097/mao.0000000000002521.
[31] McRackan TR, Abdellatif WM, Wanna GB, et al. Evaluation of second look procedures for pediatric cholesteatomas[J]. Otolaryngol-Head Neck Surg, 2011, 145(1): 154-160. doi:10.1177/0194599810396624.
[32] Bazzi K, Wong E, Jufas N, et al. Diffusion-weighted magnetic resonance imaging in the detection of residual and recurrent cholesteatoma in children: a systematic review and meta-analysis[J]. Int J Pediatr Otorhinolaryngol, 2019, 118: 90-96. doi:10.1016/j.ijporl.2018.12.031.
[33] Sharifian H, Taheri E, Borghei P, et al. Diagnostic accuracy of non-echo-planar diffusion-weighted MRI versus other MRI sequences in cholesteatoma[J]. J Med Imaging Radiat Oncol, 2012, 56(4): 398-408. doi:10.1111/j.1754-9485.2012.02377.x.
[34] Harris L, Cushing SL, Hubbard B, et al. Impact of cleft palate type on the incidence of acquired cholesteatoma[J]. Int J Pediatr Otorhinolaryngol, 2013, 77(5): 695-698. doi:10.1016/j.ijporl.2013.01.020.
[35] Lourençone LFM, Batistão GT, de Cassia Rillo Dutka J, et al. Management of acquired cholesteatoma in patients with craniofacial anomalies: an institutional experience[J]. Am J Otolaryngol, 2020, 41(6): 102591. doi:10.1016/j.amjoto.2020.102591.
[36] Beckman A, Conway GS, Cadge B. Audiological features of Turner's syndrome in adults[J]. Int J Audiol, 2004, 43(9): 533-544. doi:10.1080/14992020400050068.
[37] Verver EJ, Freriks K, Thomeer HG, et al. Ear and hearing problems in relation to karyotype in children with Turner syndrome[J]. Hear Res, 2011, 275(1/2): 81-88. doi:10.1016/j.heares.2010.12.007.
[38] Lim DB, Gault EJ, Kubba H, et al. Cholesteatoma has a high prevalence in Turner syndrome, highlighting the need for earlier diagnosis and the potential benefits of otoscopy training for paediatricians[J]. Acta Paediatr, 2014, 103(7): e282-e287. doi:10.1111/apa.12622.
[39] 郝津生, 苏畅, 闫洁, 等. 儿童Turner综合征听力学特点[J]. 中华耳科学杂志, 2015, 13(3): 440-444. doi:10.3969/j.issn.1672-2922.2015.03.013. HAO Jinsheng, SU Chang, YAN Jie, et al. Audiologic features of ethnic Chinese patients with Turner syndrome[J]. Chin J Otol, 2015, 13(3): 440-444. doi:10.3969/j.issn.1672-2922.2015.03.013.
[40] Zanetti D, di Lella F, Negri M, et al. Surgical management of middle ear cholesteatoma in children with Turner syndrome: a multicenter experience[J]. Acta Biomed, 2018, 89(3): 382-388. doi:10.23750/abm.v89i3.5409.
[41] Spinner A, Munjuluru A, Wootten CT. Prevalence of cholesteatoma in children with Down syndrome receiving treatment at pediatric health care facilities[J]. JAMA Otolaryngol Head Neck Surg, 2020, 146(9): 864-865. doi:10.1001/jamaoto.2020.1854.
[42] Ghadersohi S, Bhushan B, Billings KR. Challenges and outcomes of cholesteatoma management in children with Down syndrome[J]. Int J Pediatr Otorhinolaryngol, 2018, 106: 80-84. doi:10.1016/j.ijporl.2018.01.016.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed